Serum levels of gelatinase associated lipocalin as indicator of the inflammatory status in coronary artery disease

International Journal of Inflammation

Volumn 2012, Issue , 2012, Pages

  Kafkas, Nikolaos ^a   Demponeras, Christos ^a   Zoubouloglou, Filitsa ^a   Spanou, Loukia ^a   Babalis, Dimitrios ^a   Makris, Konstantinos ^a  

^a KAT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL COUNT; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

EID: 84876510911     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2012/189797     Document Type: Article

References (40)

1. Ross R., Atherosclerosisan inflammatory disease. The New England Journal of Medicine 1999 340 115 126
2. Falk E., Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. British Heart Journal 1983 50 2 127 134 2-s2.0-0020639814 (Pubitemid 13027014)
3. Van der Wal A. C., Becker A. E., Van der Loos C. M., Das P. K., Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994 89 1 36 44 2-s2.0-0028085059 (Pubitemid 24026469)
4. Ott I., Neumann F. J., Gawaz M., Schmitt M., Schömig A., Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 1996 94 6 1239 1246 2-s2.0-0029815017 (Pubitemid 26307248)
5. Järemo P., Hansson G., Nilsson O., Elevated inflammatory parameters are associated with lower platelet density in acute myocardial infarctions with ST-elevation. Thrombosis Research 2000 100 6 471 478 2-s2.0-0034671901 10.1016/S0049-3848(00)00366-2 (Pubitemid 32056299)
6. Buffon A., Biasucci L. M., Liuzzo G., D'Onofrio G., Crea F., Maseri A., Widespread coronary inflammation in unstable angina. The New England Journal of Medicine 2002 347 1 5 12 2-s2.0-0037019329 10.1056/NEJMoa012295 (Pubitemid 34728951)
7. Patel P. B., Pfau S. E., Cleman M. W., Brennan J. J., Howes C., Remetz M., Cabin H. S., Setaro J. F., Rinder H. M., Comparison of coronary artery specific leukocyte-platelet conjugate formation in unstable versus stable angina pectoris. American Journal of Cardiology 2004 93 4 410 413 2-s2.0-1242270517 10.1016/j.amjcard.2003.10.033 (Pubitemid 38221346)
8. Naruko T., Ueda M., Haze K., Van der Wal A. C., Van der Loos C. M., Itoh A., Komatsu R., Ikura Y., Ogami M., Shimada Y., Ehara S., Yoshiyama M., Takeuchi K., Yoshikawa J., Becker A. E., Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002 106 23 2894 2900 2-s2.0-0037016059 10.1161/01.CIR.0000042674.89762.20 (Pubitemid 35424738)
9. Madjid M., Awan I., Willerson J. T., Casscells S. W., Leukocyte count and coronary heart disease: implications for risk assessment. Journal of the American College of Cardiology 2004 44 10 1945 1956 2-s2.0-8144223156 10.1016/j.jacc.2004.07.056 (Pubitemid 39473277)
10. Särndahl E., Bergström I., Brodin V. P., Nijm J., Setterud H. L., Jonasson L., Neutrophil activation status in stable coronary artery disease. PLoS ONE 2007 2 10 2-s2.0-42349116102 10.1371/journal.pone.0001056 e1056 (Pubitemid 351552223)
11. Goldmann B. U., Rudolph V., Rudolph T. K., Holle A. K., Hillebrandt M., Meinertz T., Baldus S., Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction. Free Radical Biology and Medicine 2009 47 1 79 83 2-s2.0-67349168178 10.1016/j.freeradbiomed.2009.04.004
12. Galis Z. S., Sukhova G. K., Lark M. W., Libby P., Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. Journal of Clinical Investigation 1994 94 6 2493 2503 2-s2.0-0028063408 (Pubitemid 24379627)
13. Kai H., Ikeda H., Yasukawa H., Kai M., Seki Y., Kuwahara F., Ueno T., Sugi K., Imaizumi T., Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. Journal of the American College of Cardiology 1998 32 2 368 372 2-s2.0-0032145662 10.1016/S0735-1097(98)00250-2 (Pubitemid 28396484)
14. Schmidt-Ott K. M., Mori K., Jau Y. L., Kalandadze A., Cohen D. J., Devarajan P., Barasch J., Dual action of neutrophil gelatinase-associated lipocalin. Journal of the American Society of Nephrology 2007 18 2 407 413 2-s2.0-33846682720 10.1681/ASN.2006080882 (Pubitemid 46193306)
15. Hemdahl A. L., Gabrielsen A., Zhu C., Eriksson P., Hedin U., Kastrup J., Thorén P., Hansson G. K., Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 1 136 142 2-s2.0-33644829033 10.1161/01.ATV.0000193567.88685.f4 (Pubitemid 43732240)
16. Soni S. S., Ronco C., Katz N., Cruz D. N., Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purification 2009 28 3 165 174 2-s2.0-67649886919 10.1159/000227785
17. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A., Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. American Journal of Kidney Diseases 2009 54 6 1012 1024 2-s2.0-70449637194 10.1053/j.ajkd.2009.07.020
18. Elneihoum A. M., Falke P., Hedblad B., Lindgärde F., Ohlsson K., Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 1997 131 1 79 84 2-s2.0-0030910574 10.1016/S0021-9150(96)06077-7 (Pubitemid 27240100)
19. Elneihoum A. M., Falke P., Axelsson L., Lundberg E., Lindgärde F., Ohlsson K., Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 1996 27 10 1734 1738 2-s2.0-0029762478 (Pubitemid 26332495)
20. Falke P., Elneihoum A. M., Ohlsson K., Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia. Cerebrovascular Diseases 2000 10 2 97 101 2-s2.0-0033974568 10.1159/000016037 (Pubitemid 30107503)
21. Folkesson M., Kazi M., Zhu C., Silveira A., Hemdahl A. L., Hamsten A., Hedin U., Swedenborg J., Eriksson P., Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thrombosis and Haemostasis 2007 98 2 427 433 2-s2.0-34547902858 10.1160/TH06-11-0638 (Pubitemid 47250247)
22. Leclercq A., Houard X., Philippe M., Ollivier V., Sebbag U., Meilhac O., Michel J. B., Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. Journal of Leukocyte Biology 2007 82 6 1420 1429 2-s2.0-37249010527 10.1189/jlb.1106671 (Pubitemid 350276953)
23. Reape T. J., Groot P. H. E., Chemokines and atherosclerosis. Atherosclerosis 1999 147 2 213 225 2-s2.0-0032760728 10.1016/S0021-9150(99) 00346-9 (Pubitemid 29512252)
24. Choi K. M., Lee J. S., Kim E. J., Baik S. H., Seo H. S., Choi D. S., Oh D. J., Park C. G., Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. European Journal of Endocrinology 2008 158 2 203 207 2-s2.0-38949127057 10.1530/EJE-07-0633 (Pubitemid 351298537)
25. Zografos T., Haliassos A., Korovesis S., Giazitzoglou E., Voridis E., Katritsis D., Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. American Journal of Cardiology 2009 104 7 917 920 2-s2.0-70249126199 10.1016/j.amjcard.2009.05.023
26. Libby P., Ridker P. M., Maseri A., Inflammation and atherosclerosis. Circulation 2002 105 9 1135 1143 2-s2.0-0037022910 10.1161/hc0902.104353 (Pubitemid 34212626)
27. Apple F. S., Wu A. H. A., Mair J., Ravkilde J., Panteghini M., Tate J., Pagani F., Christenson R. H., Mockel M., Danne O., Jaffe A. S., Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clinical Chemistry 2005 51 5 810 824 2-s2.0-20244384861 10.1373/clinchem.2004.046292 (Pubitemid 40577917)
28. Davies M. J., Thomas A., Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. The New England Journal of Medicine 1984 310 18 1137 1140 2-s2.0-0021244574 (Pubitemid 14135387)
29. Naruko T., Ueda M., Haze K., Van der Wal A. C., Van der Loos C. M., Itoh A., Komatsu R., Ikura Y., Ogami M., Shimada Y., Ehara S., Yoshiyama M., Takeuchi K., Yoshikawa J., Becker A. E., Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002 106 23 2894 2900 2-s2.0-0037016059 10.1161/01.CIR.0000042674.89762.20 (Pubitemid 35424738)
30. Libby P., Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001 104 3 365 372 2-s2.0-0035902456 (Pubitemid 32666962)
31. Libby P., Simon D. I., Inflammation and thrombosis: the clot thickens. Circulation 2001 103 13 1718 1720 2-s2.0-0035799341 (Pubitemid 32291406)
32. Kjeldsen L., Johnsen A. H., Sengelov H., Borregaard N., Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. Journal of Biological Chemistry 1993 268 14 10425 10432 2-s2.0-0027256664 (Pubitemid 23150227)
33. Bundgaard J. R., Sengelov H., Borregaard N., Kjeldsen L., Molecular cloning and expression of a cDNA encoding NGAL: a lipocalin expressed in human neutrophils. Biochemical and Biophysical Research Communications 1994 202 3 1468 1475 2-s2.0-0028065442 10.1006/bbrc.1994.2096 (Pubitemid 24265933)
34. Mishra J., Qing M. A., Prada A., Mitsnefes M., Zahedi K., Yang J., Barasch J., Devarajan P., Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. Journal of the American Society of Nephrology 2003 14 10 2534 2543 2-s2.0-0141678253 10.1097/01.ASN.0000088027.54400.C6 (Pubitemid 37169339)
35. Mishra J., Dent C., Tarabishi R., Mitsnefes M. M., Ma Q., Kelly C., Ruff S. M., Zahedi K., Shao M., Bean J., Mori K., Barasch J., Devarajan P., Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. The Lancet 2005 365 9466 1231 1238 2-s2.0-20144388328 10.1016/S0140-6736(05)74811-X (Pubitemid 40469655)
36. Reghunathan R., Jayapal M., Hsu L. Y., Chng H. H., Tai D., Leung B. P., Melendez A. J., Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunology 2005 6, article 2 2-s2.0-19944419885 10.1186/1471-2172-6-2 (Pubitemid 41418122)
37. Gwira J. A., Wei F., Ishibe S., Ueland J. M., Barasch J., Cantley L. G., Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in Vitro. Journal of Biological Chemistry 2005 280 9 7875 7882 2-s2.0-14844331424 10.1074/jbc.M413192200 (Pubitemid 40349684)
38. Cowland J. B., Sorensen O. E., Sehested M., Borregaard N., Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 β but not by TNF- α Journal of Immunology 2003 171 12 6630 6639 2-s2.0-0346996867 (Pubitemid 37532095)
39. Jayaraman A., Roberts K. A., Yoon J., Yarmush D. M., Duan X., Lee K., Yarmush M. L., Identification of neutrophil gelatinase-associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte-secreted protein response to IL-1 β: a proteomic analysis. Biotechnology and Bioengineering 2005 91 4 502 515 2-s2.0-23244465337 10.1002/bit.20535 (Pubitemid 41099036)
40. Şahinarslan A., Kocaman S. A., Bas D., Akyel A., Ercin U., Zengin O., Timurkaynak T., Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease. Coronary Artery Disease 2011 22 5 333 338 2-s2.0-79960699197 10.1097/MCA.0b013e3283472a71